Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B Gel for the Treatment of Cervical High Risk HPV Infection

NCT00312286 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00312286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00312286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B Gel for the Treatment of Cervical High Risk HPV Infection
Lead sponsor
Takeda
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2006
Completion date
June 30, 2008
Enrollment
538 (actual)
Sites
93

Conditions

As the registry lists them; a condition with its own page is linked.

papillomavirus infections